SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-052703
Filing Date
2023-10-12
Accepted
2023-10-12 16:46:26
Documents
1
Period of Report
2023-10-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1477
  Complete submission text file 0001209191-23-052703.txt   2849
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Issuer) CIK: 0001472012 (see all company filings)

IRS No.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ENAVATE SCIENCES 2884 SAND HILL RD., STE 100 MENLO PARK CA 94025
Business Address
Boylan James P (Reporting) CIK: 0001953094 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39580 | Film No.: 231323175